BeOne Medicines Ltd. (ONC) stock
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/301935% above fair value
$416.54+0.58 (+0.14%)
Close on Nov 13, 2026Market cap $47.36BP/E 53.4Yield –
BeOne Medicines statistics
101 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 8.19
- 2.22
- P/OCF Ratio
- 29.78
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 6.48
- 2.57
- EV / EBIT
- 36.30
- 19.31
- EV / FCF
- 29.52
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 4.31%
- 10.8%
- Shares Change (QoQ)
- 0.96%
- 0.50%
- Float
- 1.27B
- 49M
- Shares Held by Insiders
- 14.2%
- 11.7%
- Shares Held by Institutions
- 2.37%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -10.6%
- -0.80%
- Days to Cover
- 4.37
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $424.73
- –
- 52-Week Low
- $253.95
- –
- 20-Day Moving Average
- $386.76
- –
- 50-Day Moving Average
- $369.18
- –
- 200-Day Moving Average
- $327.80
- –
- Average True Range (14)
- $12.44
- –
- Price Change (1 Week)
- 2.35%
- -1.15%
- Price Change (1 Month)
- 11.4%
- -4.87%
- Price Change (3 Months)
- 14.9%
- -21.0%
- Price Change (6 Months)
- 42.0%
- -20.6%
- Price Change (YTD)
- 37.1%
- -23.6%
- Price Change (1 Year)
- 10.4%
- -22.4%
- Price Change (3 Years)
- 106.6%
- -29.5%
- Price Change (5 Years)
- 10.00%
- -77.9%
- Price Change (10 Years)
- 1088.4%
- -65.4%
- Average Volume (10 Days)
- 568,534
- –
- Average Volume (20 Days)
- 467,036
- –
- Average Volume (90 Days)
- 410,191
- –
- Relative Volume
- 0.85
- 0.70
- Relative Strength Index (14)
- 67.5
- 43.4
- Volatility (1 Year)
- 34.2%
- 80.1%
- Beta (5 Years)
- 1.05
- 1.07
MarginsIndustry
- Pretax Margin
- 17.1%
- -11.6%
- EBITDA Margin
- 20.5%
- -27.7%
- FCF Margin
- 21.9%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 18.4%
- -49.9%
- Return on Assets (ROA)
- 10.5%
- -40.6%
- Return on Invested Capital (ROIC)
- 88.9%
- -32.9%
- Return on Capital Employed (ROCE)
- 15.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 3.55
- 3.30
- Quick Ratio
- 3.08
- 2.39
- Debt / Equity
- 0.21
- 0.49
- Debt / EBITDA
- 0.89
- 3.15
- Debt / FCF
- 0.83
- 4.65
- Net Debt / EBITDA
- -3.37
- 1.97
- Interest Coverage
- 8.31
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 32.9%
- 6.82%
- Net Income Growth (YoY)
- 1235.6%
- -14.4%
- EPS Growth (YoY)
- 1900.0%
- -12.3%
- FCF Growth (YoY)
- 166.1%
- 6.85%
- Revenue Growth (3Y CAGR)
- 55.7%
- 2.25%
- Revenue Growth (5Y CAGR)
- 76.8%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.75
- 0.40
- Inventory Turnover
- 1.05
- 2.73
- Revenue Per Employee
- $550.54K
- $429.29K
- Profits Per Employee
- $76.30K
- -$689.41K
- Employee Count
- 12,000
- 74
- WACC
- 10.3%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $1.13B
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $4.58B
- $17.76M
- Net Cash Per Share
- $3.10
- $0.80
- Equity (Book Value)
- $5.82B
- $53.89M
- Book Value Per Share
- $3.94
- $1.50
- Tangible Book Value
- $5.78B
- $27.13M
- Working Capital
- $5.70B
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$140.96M
- -$1.00M
- FCF Per Share
- $0.98
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 1.93%
- -21.8%
- FCF Yield
- 3.06%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $141.91M
- $2.90M
- Income Tax
- $215.70M
- $73.00K
- Effective Tax Rate
- 19.1%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $7.29
- $19.34
- Graham Upside
- -77.2%
- -46.6%
- Altman Z-Score
- 7.70
- 0.23
- Piotroski F-Score
- 7
- 4
- Beneish M-Score
- -2.73
- -2.63
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ONC | S&P 500 | Difference | ONC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +19.3% | -3.0% | +22.4 pts | ||
| 3 months | +17.0% | -2.8% | +19.8 pts | ||
| Year to date | +37.1% | +11.5% | +25.6 pts | ||
| 1 year | +13.1% | +13.5% | −0.4 pts | ||
| 3 years | +109.5% | +77.7% | +31.8 pts | +28.0% | +21.1% |
| 5 years | +10.0% | +72.6% | −62.6 pts | +1.9% | +11.5% |
| 10 years | +1193.6% | +308.2% | +885.4 pts | +29.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M ONC shares were sold short on Oct 30, 2026, down 10.6% from the previous report. At recent volumes it would take 4.4 days to buy them back. Over the last 20 sessions, 58.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,602,619 | -10.6% | 366,722 | 4.4 |
| Oct 15, 2026 | 1,792,875 | -7.3% | 367,896 | 4.9 |
| Sep 30, 2026 | 1,933,092 | +13.2% | 389,451 | 5.0 |
| Sep 15, 2026 | 1,707,474 | +20.0% | 378,473 | 4.5 |
| Aug 31, 2026 | 1,422,559 | +11.5% | 341,689 | 4.2 |
| Aug 14, 2026 | 1,276,075 | +44.9% | 455,798 | 2.8 |
| Jul 31, 2026 | 880,627 | -5.0% | 372,520 | 2.4 |
| Jul 15, 2026 | 926,986 | +17.1% | 352,696 | 2.6 |
| Jun 30, 2026 | 791,577 | -12.3% | 296,408 | 2.7 |
| Jun 15, 2026 | 902,392 | -17.2% | 311,622 | 2.9 |
| May 29, 2026 | 1,089,330 | +4.1% | 222,577 | 4.9 |
| May 15, 2026 | 1,046,818 | -5.8% | 252,348 | 4.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?